Management of Hemangiomas

Risk Assessment and Management

The American Academy of Pediatrics recommends that most infantile hemangiomas undergo spontaneous involution without treatment, with 90% of involution complete by 4 years of age 2
Observation is recommended for asymptomatic, non-problematic lesions that don't threaten function or cause disfigurement, as suggested by the American Academy of Pediatrics 1, 2
Regular monitoring should be conducted to assess for growth and potential complications in patients with hemangiomas, according to the American Academy of Pediatrics 2

The American Academy of Pediatrics recommends oral propranolol as the first-line treatment for complicated infantile hemangiomas, with a recommended dose of 2 mg/kg/day in three divided doses 1, 2
Propranolol has largely replaced corticosteroids due to its superior efficacy and safety profile, as stated by the American Academy of Pediatrics 3
Topical beta-blockers (timolol 0.5% gel-forming solution) may be useful for superficial or intraocular hemangiomas with less systemic absorption, according to the American Academy of Pediatrics 3, 4

Resection during infancy is generally not recommended due to greater risks of anesthetic morbidity, blood loss, and iatrogenic injury, as suggested by the American Academy of Pediatrics 3
Most surgical interventions are best delayed until after infancy to allow for natural involution, with optimal timing before 4 years of age, according to the American Academy of Pediatrics 3, 1

Periocular hemangiomas require early evaluation by a pediatric ophthalmologist to prevent astigmatism, strabismus, or amblyopia, as recommended by the American Academy of Pediatrics 3
Propranolol is preferred over intralesional steroids due to risk of retinal artery embolization in patients with periocular hemangiomas, according to the American Academy of Pediatrics 3
Infants with cutaneous hemangiomas should be screened for hepatic lesions with ultrasonography, as suggested by the American Academy of Pediatrics 5, 1

Infants with significant multifocal or diffuse hemangiomas should undergo thyroid hormone screening as the tumor can deactivate thyroid hormone, according to the American Academy of Pediatrics 5
Referral to a specialist or multidisciplinary vascular anomaly center is recommended when complications are likely or intervention threshold is uncertain, as stated by the American Academy of Pediatrics 5